Multimodal Nanoagents for the Detection of Intravascular Thrombi
View/ Open
Author
McCarthy, Jason R.
Patel, Purvish
Botnaru, Ion
Haghayeghi, Pouneh
Weissleder, Ralph
Jaffer, Farouc A.
Published Version
https://doi.org/10.1021/bc9001163Metadata
Show full item recordCitation
McCarthy, Jason R., Purvish Patel, Ion Botnaru, Pouneh Haghayeghi, Ralph Weissleder, and Farouc A. Jaffer. 2009. “Multimodal Nanoagents for the Detection of Intravascular Thrombi.” Bioconjugate Chemistry 20 (6): 1251–55. https://doi.org/10.1021/bc9001163.Abstract
Thrombosis underlies numerous life-threatening cardiovascular syndromes. Development of thrombosis-specific molecular imaging agents to detect and monitor thrombogenesis and fibrinolysis in vivo could improve the diagnosis, risk stratification, and treatment of thrombosis syndromes. To this end, we have synthesized efficient multimodal nanoagents targeted to two different constituents of thrombi, namely, fibrin and activated factor XIII. These agents are targeted via the conjugation of peptide-targeting ligands to the surface of fluorescently labeled magnetic nanoparticles. As demonstrated by in vitro and in vivo studies, both nanoagents possess high affinities for thrombi, and enable mutimodal fluorescence and magnetic resonance imaging.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41384211
Collections
- HMS Scholarly Articles [17852]
Contact administrator regarding this item (to report mistakes or request changes)